2024³â 12¿ù 24ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Boomi Launches New Veeva Vault Connector to Simplify Application Integration in the Life Sciences Industry

Boomi connector streamlines integration of third-party applications with Veeva Vault, uniting content and data for seamless, end-to-end business processes
´º½ºÀÏÀÚ: 2024-11-04

CONSHOHOCKEN, PA. -- Boomi™, the intelligent integration and automation leader, announced the launch of a new specialized connector designed to streamline integration between third-party systems and the Veeva Vault platform. This expands Boomi’s collaboration with Veeva Systems, a leading global provider of cloud-based software solutions for the life sciences industry, to bring together content and data for mutual customers.

As life sciences companies increasingly modernize operations with advanced solutions, the demand for seamless connectivity for their Veeva applications - from commercial to R&D, and quality - with complementary business applications continues to grow. The Boomi connector for Veeva Vault simplifies this process by leveraging the latest Vault APIs for comprehensive data access. By enabling users to avoid manual, time-consuming, and error-prone coding projects, the connector streamlines the integration process and drives efficiency gains.

“The integration of the Veeva Vault Platform with other applications and data sources is critical for life sciences companies looking to modernize their operations,” said Ed Macosky, Chief Product and Technology Officer at Boomi. “Boomi is committed to being the go-to integration platform for Veeva customers, simplifying the integration process while meeting the unique requirements of the life sciences and pharmaceutical industries.”

Key Advantages of the Boomi Connector for Veeva Vault:

· Streamlined Connectivity: The Boomi connector for Veeva Vault simplifies the integration process, leveraging the latest Vault APIs for comprehensive data access. This alleviates the burden of manual coding while enhancing the user experience.
· Low-Code Development Environment: The Boomi Enterprise Platform allows researchers and business stakeholders to quickly create and deploy integrations, automating their processes without the need for extensive coding expertise.
· Flexible and Secure: With options for cloud, on-premises, and hybrid deployments, Veeva customers can configure their integration services to meet stringent regulatory compliance standards, including HIPAA.
· Automation for Accelerated Business Processes: Once integrated, Veeva customers can leverage the Boomi Enterprise Platform to automate workflows using Veeva Vault data, enhancing operational efficiency and driving faster decision-making.

“Veeva Vault is the foundation for drug development and commercialization in life sciences. Seamless integration of Vault applications, including Vault CRM, with other third-party systems is essential for operational efficiency,” said Jared Katz, Senior Director, Veeva Development Cloud Strategy. “With its low-code platform and connector to Vault, Boomi helps to streamline and simplify the integration process.”



 Àüü´º½º¸ñ·ÏÀ¸·Î

The Next Gen of AI Awaits, GIGABYTE Sets the Benchmark for HPC at CES 2025
SpaceRISE Signs Concession Contract to Deliver Europe¡¯s IRIS©÷ Connectivity Network
Boomi Boosts Data Management Capabilities With Acquisition of Modern Data Integration Provider Rivery
Korean Robotaxi Startup Sonnet.AI Secures Level 4 Autonomous Shuttles Certification
KIOXIA NVMe SSD Cryptographic Module Achieves FIPS 140-3 Level 2 Validation
CHMP Recommends Approval of Galderma¡¯s Nemolizumab for Moderate-to-Severe Atopic Dermatitis
BrightPath Bio and Cellistic Announced Process Development and Manufacturing Collaboration

 

Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engi...
PDC*line Pharma Presents Primary Clinical Results From Phase I/II Tria...
Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Th...
Abu Dhabi¡¯s Technology Innovation Institute Inaugurates Open-Source A...
DNP Achieves Fine Pattern Resolution on EUV Lithography Photomasks for...
Octapharma Injects Efficiency Into Its Supply Chain With Kinaxis
Kioxia Develops OCTRAM (Oxide-Semiconductor Channel Transistor DRAM) T...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚÇ¥±â 'ãæÚ¤ó¢'
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á
¾Ë¶ã°Ç¼³, »óÇ¥µî·Ï ¿Ï·á
Á¸Â÷´åÄÄ, ±Û²Ã º¯°æ »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..